Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

YOU WONT BELIEVE: Tyler radke | Mind Blowing Facts

Up 93% in 2026, Does Nebius Stock Have More Room to Run?

With an impressive double digit rise this year, based on expanding operations, can Nebius Group offer more to its investors?

Citi Just Downgraded DocuSign. Should You Ditch DOCU Stock Here?

Citi Just Downgraded DocuSign. Should You Ditch DOCU Stock Here?

DocuSign stock is sinking after Citi trimmed its price target on the firm nearly in half. Insiders have also been unloading DOCU shares in 2026.

Why Citi Analysts Think You Should Buy Microsoft Stock Now

Why Citi Analysts Think You Should Buy Microsoft Stock Now

Citi is keeping the faith in Microsoft, and the numbers from its latest earnings report make a strong case for why.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Citi Is Betting on Another ‘Supercycle’ in Palantir Stock. Should You Buy PLTR Here?

Citi is bullish on PLTR stock, citing the AI giant's widening moat and stellar revenue growth.

Should You Buy the Post-Earnings Pop in Snowflake Stock?

Snowflake stock soars on stellar earnings and upbeat guidance. A Citi analyst says it’s still not too late to invest in SNOW shares.

Palantir's 70x Revenue Valuation May Be Unsustainable Despite 'Outstanding Q2 Results' — Citi Analyst Warns Company's 'Edge' May Fade As AI Expands

According to Tyler Radke, a senior Citigroup equity analyst, Palantir Technologies Inc.’s (NASDAQ:PLTR) lofty valuations are difficult to justify despite its “outstanding Q2 results.”

Should You Buy the Dip as Palantir Stock Falls for 7 Straight Days?

Palantir stock remains super expensive despite a more-than-20% decline in recent sessions. But Citi analyst Tyler Radke believes PLTR shares have a very durable moat.

inkl

Read news from The Economist, FT, and more,
with one subscription

Analysts Warn That CoreWeave Stock Is ‘High Risk,’ But They Still Want You to Buy CRWV Now

Analysts Warn That CoreWeave Stock Is ‘High Risk,’ But They Still Want You to Buy CRWV Now

CoreWeave stock has been on an absolute tear since its IPO in early 2025. Is CRWV stock still a good buy right now?

Cathie Wood Is Dumping Palantir Stock at Record Highs. Should You?

Cathie Wood Is Dumping Palantir Stock at Record Highs. Should You?

Cathie Wood recently sold more than $7 million worth of Palantir stock – and valuation concerns suggest PLTR shares are risky at current levels.

Beyond The Numbers: 11 Analysts Discuss Adobe Stock

Beyond The Numbers: 11 Analysts Discuss Adobe Stock

In the preceding three months, 11 analysts have released ratings for Adobe (NASDAQ:ADBE), presenting a wide array of perspectives from bullish to bearish.

A Glimpse Into The Expert Outlook On ServiceNow Through 32 Analysts

A Glimpse Into The Expert Outlook On ServiceNow Through 32 Analysts

In the latest quarter, 32 analysts provided ratings for ServiceNow (NYSE:NOW), showcasing a mix of bullish and bearish perspectives.

Expert Outlook: Autodesk Through The Eyes Of 19 Analysts

Expert Outlook: Autodesk Through The Eyes Of 19 Analysts

Throughout the last three months, 19 analysts have evaluated Autodesk (NASDAQ:ADSK), offering a diverse set of opinions from bullish to bearish.

Where Snowflake Stands With Analysts

Where Snowflake Stands With Analysts

Across the recent three months, 25 analysts have shared their insights on Snowflake (NYSE:SNOW), expressing a variety of opinions spanning from bullish to bearish.

This 'Magnificent 7' Stock is a Buy for 32% Upside Potential

This 'Magnificent 7' Stock is a Buy for 32% Upside Potential

This standout stock from the 'Magnificent 7' group is recommended for purchase with a projected 32% upside potential.

Get all your
news in one place.

100's of premium titles.
One news app.

After Underperforming in 2024, is Mega-Cap Microsoft Stock Still a Buy?

MSFT has underperformed the markets this year, but analysts still like the stock.

Up 167% in 2023, Can This AI Stock Keep Rising in 2024?

The company's strong AI-driven data analytics and software solutions continue to drive its fundamentals, with the stock up more than 42% YTD. How much higher can it go?

Adobe Is Trying to Spend $20 Billion to Buy Back Its Swagger

The company sees buying Figma as a way to overhaul its business, but critics see echoes of Facebook’s alleged practice of buying up its competition. Regulators could still block it.

Palantir's Q2 Performance Has Analysts Divided

Palantir Technologies Inc (NYSE: PLTR) clocked 26%

Get all your
news in one place.

100's of premium titles.
One news app.

Here's Why Analysts Remained Bullish On Microsoft Despite Price Target Cut

Two analysts remained bullish despite slashing their price targets on Microsoft Corp (NASDAQ:MSFT). Citigroup analyst Tyler Radke maintained Microsoft with a Buy and lowered the price target from $386 to $355 (24.8% upside). Amidst rising investor concerns around the sustainability of robust software demand and valuation multiples, Citi analyst Tyler Radke expects MSFT's results to…

Sprinklr Shares Gain As Analysts Hail Its Q4

Analysts mostly lifted their price targets on Sprinklr Inc (NYSE:CXM) following its Q4 beat. Sprinklr clocked Q4 FY21 revenue growth of 30% year-over-year to $135 million, beating the consensus of $130.38 million. Subscription revenue increased by 30.7% Y/Y to $117.69 million. "We accelerated our growth, went public, and created a new category called…

Read How Analysts Reacted To Salesforce's Q4 Results

Analysts adjusted their price targets on Salesforce.com Inc (NYSE:CRM) post Q4 results. Citi analyst Tyler Radke raised the firm's price target on Salesforce to $233 from $220 (11.5% upside) and kept a Neutral. The company "delivered a reassuring" Q4 and outlook, which should help alleviate concerns around the health of the front office and general…

Here's How Analysts View Zoom Ahead Of Its Quarterly Results

Analysts revised their price targets on Zoom Video Communications Inc (NASDAQ:ZM) ahead of its quarterly results. UBS analyst Karl Keirstead lowered the price target on Zoom to $130 from $250 (8% upside) and kept a Neutral rating on the shares ahead of its quarterly results. Despite the 35% year-to-date decline in the stock, the analyst recommends…

1

People

Gregg Moskowitz

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Wikimedia Commons

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

362,681 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play